Position in XNCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$37,938,184
+$19,119,520 QoQ
Shares Held
2,356,409
+51.0% QoQ
Ownership
3.17%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 208 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. XNCR ranks #76 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in XNCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,938,184 | 2,356,409 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,818,664 | 1,560,420 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,522,975 | 1,601,762 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,862,315 | 1,693,292 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $29,555,046 | 3,760,184 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $41,822,083 | 3,930,647 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $92,756,746 | 4,036,412 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $79,013,436 | 3,929,062 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $75,008,288 | 3,962,403 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $84,528,986 | 3,819,656 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $73,960,542 | 3,483,775 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $64,176,419 | 3,184,934 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $78,869,642 | 3,158,576 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $91,727,113 | 3,288,889 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $83,816,536 | 3,218,761 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $83,385,693 | 3,209,611 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $180,616,573 | 6,599,071 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $156,198,113 | 5,854,502 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $237,056,361 | 5,908,683 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $193,744,770 | 5,932,173 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $202,246,221 | 5,863,909 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $245,427,402 | 5,699,661 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $248,270,232 | 5,690,356 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $220,485,191 | 5,684,073 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $174,889,643 | 5,399,495 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $154,251,227 | 5,162,357 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||